Aug 2, 2024

Featuring an interview with Dr Matthew R Smith, including the following topics:

• Selection and sequencing of androgen-targeting therapies (0:00)
• Evidence-based selection of treatment for metastatic hormone-sensitive prostate cancer (25:07)
• New considerations with the use of PARP inhibitors for metastatic...

Jul 1, 2024

Featuring perspectives from Dr Neeraj Agarwal, Dr Emmanuel S Antonarakis, Dr Andrew J Armstrong, Dr Tanya B Dorff and Dr Matthew R Smith, moderated by Dr Armstrong, including the following topics:

• Introduction (0:00)
• Optimizing the Management of Nonmetastatic Prostate Cancer — Dr Dorff (3:34)
• Evidence-Based Selection...

May 30, 2024

Featuring perspectives from Dr Rahul Aggarwal, Dr Adam S Kibel, Dr Laurence Klotz and Dr Sandy Srinivas, moderated by Dr Elisabeth I Heath, including the following topics:

• Introduction (0:00)
• Recent Data Defining the Optimal Use of Hormonal Therapy for Nonmetastatic Prostate Cancer — Dr Kibel (2:39)
• Side Effects and...

May 16, 2024

Featuring perspectives from Dr Andrew J Armstrong and Ms Brenda Martone, including the following topics:

• Introduction: Overview of Prostate Cancer; Hormonal Therapy (0:00)
• Radiopharmaceuticals for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) (24:11)
• Biomarker Testing for mCRPC; PARP...

Apr 19, 2024

Featuring perspectives from Dr Emmanuel S Antonarakis and Dr Rana R McKay, including the following topics.

• Role of Hormonal Therapy in Prostate Cancer (PC) Management — Dr McKay (0:00)
• Evidence-Based Use of Other Therapeutic Approaches — Dr Antonarakis (35:15)

CME information and select...